These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 23690100)
1. Pemphigus oral lesions area index (POLAI): A new scoring scale for assessing oral pemphigus vulgaris. Wang F; Zhang X; Yao Y; Wang J; Shi Y; Liu T; Xu H; Zhou Y; Dan H; Zeng X Oral Dis; 2024 Jun; ():. PubMed ID: 38937974 [TBL] [Abstract][Full Text] [Related]
2. ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter-rater reliability and testing times. Shamabadi A; Yazdinezhad S; Sadeghi Y; Moradi AR; Yazdchi A; Teymourpour A; Faramarzi A; Seirafi R; Balighi K; Mahmoudi H; Daneshpazhooh M Oral Dis; 2023 Oct; 29(7):2696-2704. PubMed ID: 35852132 [TBL] [Abstract][Full Text] [Related]
3. Nikolsky's sign: A pathognomic boon. Maity S; Banerjee I; Sinha R; Jha H; Ghosh P; Mustafi S J Family Med Prim Care; 2020 Feb; 9(2):526-530. PubMed ID: 32318376 [TBL] [Abstract][Full Text] [Related]
5. Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases. Tseng H; Stone C; Murrell DF Front Immunol; 2023; 14():1243581. PubMed ID: 37818362 [TBL] [Abstract][Full Text] [Related]
6. The Significance of Scalp Involvement in Pemphigus: A Literature Review. Sar-Pomian M; Rudnicka L; Olszewska M Biomed Res Int; 2018; 2018():6154397. PubMed ID: 29770335 [TBL] [Abstract][Full Text] [Related]
7. Validation studies of outcome measures in pemphigus. Hanna S; Kim M; Murrell DF Int J Womens Dermatol; 2016 Dec; 2(4):128-139. PubMed ID: 28492025 [TBL] [Abstract][Full Text] [Related]
8. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Pfütze M; Niedermeier A; Hertl M; Eming R Eur J Dermatol; 2007; 17(1):4-11. PubMed ID: 17324820 [TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris activity score and assessment of convergent validity. Chams-Davatchi C; Rahbar Z; Daneshpazhooh M; Mortazavizadeh SM; Akhyani M; Esmaili N; Balighi K Acta Med Iran; 2013 May; 51(4):224-30. PubMed ID: 23690100 [TBL] [Abstract][Full Text] [Related]
10. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score. Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657 [TBL] [Abstract][Full Text] [Related]
11. An Oral Disease Severity Score validated for use in oral pemphigus vulgaris. Ormond M; McParland H; Donaldson ANA; Andiappan M; Cook RJ; Escudier M; Hullah E; Higham J; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF Br J Dermatol; 2018 Oct; 179(4):872-881. PubMed ID: 29297927 [TBL] [Abstract][Full Text] [Related]
12. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835 [TBL] [Abstract][Full Text] [Related]
13. Reliability and convergent validity of two outcome instruments for pemphigus. Rosenbach M; Murrell DF; Bystryn JC; Dulay S; Dick S; Fakharzadeh S; Hall R; Korman NJ; Lin J; Okawa J; Pandya AG; Payne AS; Rose M; Rubenstein D; Woodley D; Vittorio C; Werth BB; Williams EA; Taylor L; Troxel AB; Werth VP J Invest Dermatol; 2009 Oct; 129(10):2404-10. PubMed ID: 19357707 [TBL] [Abstract][Full Text] [Related]